Genzyme Corp. has plans to build a new R&D center in Beijing as part of its ongoing global expansion and commitment to establishing a long-term presence in China. The total cost for the project is estimated to be $90 million.     The new R&D facility will be used for Genzyme’s key areas of focus, including orthopedics, transplant and immune disease, oncology, endocrinology and cardiovascular disease. The facility, which will incorporate a green design, will include laboratory-sc...